Single-source·Aug 26, 2026·1 sources analyzed
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
Could affect taxpayer-funded Medicare, patients relying on diagnostic tests, and enforcement against companies submitting false claims.
Image: Modern Action subject: Fraud, waste, abuse, and payment integrity
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Fraud, waste, abuse, and payment integrity
See the current decision, choose your position, and send a message through the issue page.
Take action on Fraud, waste, abuse, and payment integrity